$5.63 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 143 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INVITAE CORPnote 2.000% 9/0 | $221,666,000 | -9.8% | 163,385,000 | 0.0% | 3.94% | -23.8% | ||
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $131,241,000 | -0.5% | 80,000,000 | 0.0% | 2.33% | -15.9% | ||
| EWTX | EDGEWISE THERAPEUTICS INC | $83,894,000 | -34.4% | 3,933,137 | 0.0% | 1.49% | -44.5% | |
| INSULET CORPnote 0.375% 9/0 | $78,182,000 | +2.7% | 57,581,000 | 0.0% | 1.39% | -13.2% | ||
| AFIB | ACUTUS MED INC | $73,724,000 | +27.0% | 4,341,799 | 0.0% | 1.31% | +7.4% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $70,557,000 | +0.1% | 725,000 | 0.0% | 1.25% | -15.5% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $59,632,000 | -12.8% | 3,448,912 | 0.0% | 1.06% | -26.3% | |
| MOH | MOLINA HEALTHCARE INC | $58,653,000 | +8.3% | 231,776 | 0.0% | 1.04% | -8.5% | |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $51,920,000 | +9.2% | 57,791,000 | 0.0% | 0.92% | -7.7% | ||
| CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $47,809,000 | +3.2% | 49,064,000 | 0.0% | 0.85% | -12.8% | ||
| SWTX | SPRINGWORKS THERAPEUTICS INC | $46,032,000 | +12.0% | 558,574 | 0.0% | 0.82% | -5.3% | |
| TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $45,640,000 | +2.1% | 45,000,000 | 0.0% | 0.81% | -13.7% | ||
| NOVAVAX INCnote 3.750% 2/0 | $44,647,000 | +8.8% | 25,000,000 | 0.0% | 0.79% | -8.1% | ||
| ONCR | ONCORUS INC | $43,456,000 | -0.9% | 3,148,977 | 0.0% | 0.77% | -16.2% | |
| NUVASIVE INCnote 0.375% 3/1 | $39,639,000 | -3.0% | 40,000,000 | 0.0% | 0.70% | -18.0% | ||
| RYTM | RHYTHM PHARMACEUTICALS INC | $38,957,000 | -7.9% | 1,989,625 | 0.0% | 0.69% | -22.2% | |
| ISEE | IVERIC BIO INC | $36,392,000 | +2.1% | 5,767,409 | 0.0% | 0.65% | -13.8% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $34,607,000 | -5.6% | 3,769,795 | 0.0% | 0.62% | -20.1% | |
| BDSI | BIODELIVERY SCIENCES INTL IN | $34,117,000 | -8.4% | 9,530,000 | 0.0% | 0.61% | -22.6% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $30,508,000 | -39.5% | 6,949,416 | 0.0% | 0.54% | -48.9% | |
| TERN | TERNS PHARMACEUTICALS INC | $28,761,000 | -44.3% | 2,345,959 | 0.0% | 0.51% | -52.9% | |
| GRAY | GRAYBUG VISION INC | $28,680,000 | -2.2% | 5,281,713 | 0.0% | 0.51% | -17.4% | |
| XERIS PHARMACEUTICALS INCnote 5.000% 7/1 | $28,545,000 | -6.2% | 18,000,000 | 0.0% | 0.51% | -20.7% | ||
| ITMR | ITAMAR MED LTDsponsored ads | $28,114,000 | -1.7% | 1,193,803 | 0.0% | 0.50% | -17.0% | |
| XLRN | ACCELERON PHARMA INC | $27,545,000 | -7.5% | 219,500 | 0.0% | 0.49% | -21.9% | |
| XERS | XERIS PHARMACEUTICALS INC | $26,672,000 | -9.8% | 6,553,398 | 0.0% | 0.47% | -23.7% | |
| FATE | FATE THERAPEUTICS INC | $26,384,000 | +5.3% | 304,000 | 0.0% | 0.47% | -11.0% | |
| ALEC | ALECTOR INC | $21,980,000 | +3.4% | 1,055,192 | 0.0% | 0.39% | -12.8% | |
| TIL | INSTIL BIO INC | $21,556,000 | -23.0% | 1,115,739 | 0.0% | 0.38% | -34.9% | |
| PROF | PROFOUND MED CORP | $21,232,000 | -18.8% | 1,297,797 | 0.0% | 0.38% | -31.3% | |
| NEVRO CORPnote 2.750% 4/0 | $20,863,000 | +14.6% | 12,000,000 | 0.0% | 0.37% | -3.1% | ||
| PHVS | PHARVARIS N V | $19,240,000 | -33.4% | 1,032,757 | 0.0% | 0.34% | -43.7% | |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $15,558,000 | -6.8% | 14,527,000 | 0.0% | 0.28% | -21.4% | ||
| BLUE | BLUEBIRD BIO INC | $15,360,000 | +6.1% | 480,300 | 0.0% | 0.27% | -10.2% | |
| CMRX | CHIMERIX INC | $14,530,000 | -17.0% | 1,816,221 | 0.0% | 0.26% | -29.9% | |
| MDVL | MEDAVAIL HOLDINGS INC | $13,996,000 | -12.5% | 1,142,552 | 0.0% | 0.25% | -25.9% | |
| ANNX | ANNEXON INC | $13,144,000 | -19.1% | 583,913 | 0.0% | 0.23% | -31.9% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $12,770,000 | -49.8% | 1,047,599 | 0.0% | 0.23% | -57.5% | |
| AMWL | AMERICAN WELL CORPcl a | $12,468,000 | -27.6% | 991,115 | 0.0% | 0.22% | -39.0% | |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $10,420,000 | -3.8% | 1,000,000 | 0.0% | 0.18% | -18.9% | |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $10,200,000 | +1.9% | 1,000,000 | 0.0% | 0.18% | -13.8% | |
| SNRHU | SENIOR CONNECT ACQUISITN CORunit 12/09/2023 | $10,120,000 | +1.1% | 1,000,000 | 0.0% | 0.18% | -14.3% | |
| REVHU | REVOLUTION HEALTHCAR AQ CORPunit 03/18/20266 | $10,080,000 | +0.3% | 1,000,000 | 0.0% | 0.18% | -15.2% | |
| MTACU | MEDTECH ACQUISITION CORPunit 12/18/2025 | $10,020,000 | -0.3% | 1,000,000 | 0.0% | 0.18% | -15.6% | |
| CMIIU | CM LIFE SCIENCES II INCunit 02/25/2028 | $8,070,000 | +5.1% | 600,000 | 0.0% | 0.14% | -11.2% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $7,588,000 | -15.7% | 271,191 | 0.0% | 0.14% | -28.6% | |
| TMPMU | TURMERIC ACQUISITION CORPunit 10/08/2025 | $7,545,000 | +0.6% | 750,000 | 0.0% | 0.13% | -15.2% | |
| IGNYU | IGNYTE ACQUISITION CORPunit 01/05/2026 | $7,265,000 | 0.0% | 725,000 | 0.0% | 0.13% | -15.7% | |
| TPTX | TURNING POINT THERAPEUTICS I | $6,542,000 | -17.5% | 83,846 | 0.0% | 0.12% | -30.5% | |
| DCTH | DELCATH SYS INC | $6,305,000 | +1.5% | 500,000 | 0.0% | 0.11% | -14.5% | |
| BENEFITFOCUS INCnote 1.250%12/1 | $6,130,000 | +3.3% | 6,500,000 | 0.0% | 0.11% | -12.8% | ||
| CHFWU | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $5,200,000 | +6.6% | 500,000 | 0.0% | 0.09% | -10.7% | |
| OHPAU | ORION ACQUISITION CORPunit 02/19/2026 | $4,960,000 | -0.8% | 500,000 | 0.0% | 0.09% | -16.2% | |
| XENT | INTERSECT ENT INC | $4,366,000 | -18.1% | 255,456 | 0.0% | 0.08% | -30.4% | |
| CABA | CABALETTA BIO INC | $3,993,000 | -22.5% | 464,252 | 0.0% | 0.07% | -34.3% | |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $3,542,000 | -25.1% | 733,333 | 0.0% | 0.06% | -36.4% | |
| NEOGENOMICS INCnote 0.250% 1/1 | $2,452,000 | -2.9% | 2,500,000 | 0.0% | 0.04% | -17.0% | ||
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $2,398,000 | +234.0% | 166,666 | 0.0% | 0.04% | +186.7% | |
| DFPHW | DFP HEALTHCARE ACQUISITNS CO*w exp 03/31/202 | $2,163,000 | +28.1% | 1,250,000 | 0.0% | 0.04% | +8.6% | |
| MTCR | METACRINE INC | $1,054,000 | -38.7% | 277,469 | 0.0% | 0.02% | -47.2% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $433,000 | -2.7% | 166,666 | 0.0% | 0.01% | -11.1% | |
| WINT | WINDTREE THERAPEUTICS INC | $46,000 | -6.1% | 20,148 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.